BioLife Solutions
BioLife Solutions

BioLife Solutions

Life Sciences Tools & Services
WebsiteInvestor RelationsSEC
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

$1.9B

Market Cap • 10/5/2026

1987

(39 years)

Founded

1989

(37 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

4,5

P/S

18,4

P/EBITDA

294,6

P/OCF

111,9

P/FCF

232,9

P/E

33,3

BVPS

8,6

EPS

0,3

Market Cap

Market Cap

1,9B

EV

1,8B

EV/Revenue

17,7

EV/EBITDA

284,2

EV/EBIT

611,1

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0%

Total Yield

0%

Payout

0%

Retained Earnings

-293,4M

Profitability

Gross Margin

63,9%

EBITDA Margin

6,2%

EBIT Margin

2,9%

Net Margin

49,1%

D&A/EBITDA

-14,1%

R&D/Revenue

8%

Capex/Revenue

8,5%

Capex/D&A

255,8%

Capex/OCF

52%

SBC/OCF

128,2%

% PPE

5,3%

% Goodwill

46,6%

ROE

13,2%

ROIC

—

Growth

CAGR Revenue 5Y

6,8%

CAGR Op. Income 5Y

-35,2%

CAGR Net Income 5Y

43,3%

CAGR EPS 5Y

80,8%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

9,7

Quick Ratio

5,9

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium